- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Piramal Pharma Limited — Board Meeting, 29-07-2026: Outcome of Board Meeting
29-07-2026 | 08:44 pm
29-07-2026 | 08:44 pm
Piramal Pharma's board approved Q1 FY27 financial results. Consolidated revenue hit Rs. 2,269.92 Cr, while the company reported a net loss of Rs. 69.39 Cr for the quarter.
No comments yet. Be the first to comment!